Literature DB >> 24122964

Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.

Zheng-Yan Chang1, Ran Sun, Yu-Shui Ma, Da Fu, Xiao-Long Lai, Yu-Sheng Li, Xing-Hong Wang, Xiao-Ping Zhang, Zhong-Wei Lv, Xian-Ling Cong, Wen-Ping Li.   

Abstract

Pancreatic cancer (PC) has a high rate of mortality and a poorly understood mechanism of progression. Investigation of the molecular mechanism of PC and exploration of the specific markers for early diagnosis and specific targets of therapy are key points to prevent and treat PC effectively and to improve their prognosis. In our study, expression profiles experiment of para-carcinoma, carcinoma and relapse human PC was performed using Agilent human whole genomic oligonucleotide microarrays with 45 000 probes. Differentially expressed genes related with PC were screened and analysed further by Gene Ontology term analysis and Kyoto encyclopaedia of genes and genomes pathway analysis. Our results showed that there were 3853 differentially expressed genes associated with pancreatic carcinogenesis and relapse. In addition, our study found that PC was related to the Jak-STAT signalling pathway, PPAR signalling pathway and Calcium signalling pathway, indicating their potential roles in pancreatic carcinogenesis and progress.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Jak-STAT signalling pathway; PPAR signalling pathway; calcium signalling pathway; carcinogenesis; microarray; pancreatic cancer; relapse

Mesh:

Year:  2013        PMID: 24122964     DOI: 10.1002/cbf.3009

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  3 in total

Review 1.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer.

Authors:  X-L Lai; Y-H Huang; Y-S Li; G-N Li; L-P Wang; R Sun; Y-S Ma; S-Y Feng; Z-Y Chang; X-H Wang; D Fu; X Han; X-L Cong; W-P Li
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

3.  Genomic expression profiling and bioinformatics analysis of pancreatic cancer.

Authors:  Dong-Yan Han; Da Fu; Hao Xi; Qian-Yu Li; Li-Jin Feng; Wei Zhang; Guo Ji; Jia-Cheng Xiao; Qing Wei
Journal:  Mol Med Rep       Date:  2015-06-11       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.